Old Web
English
Sign In
Acemap
>
authorDetail
>
Arlhee Díaz-Miqueli
Arlhee Díaz-Miqueli
Nimotuzumab
Medicine
Epidermal growth factor receptor
Antibody
Monoclonal antibody
5
Papers
71
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Fab(nimotuzumab)-HYNIC-99mTc: Antibody Fragmentation for Molecular Imaging Agents.
2016
Anti-cancer Agents in Medicinal Chemistry
Victoria Calzada
María Fernanda García
Luis Michel Alonso-Martínez
Ximena Camachoc
Enzo Goicochea
Marcelo Fernández
Abmel Xiques Castillo
Arlhee Díaz-Miqueli
Normando Iznaga Escobar
René Leyva Montaña
Omar Alonso
Juan Pablo Gambini
Pablo Cabral
Show All
Source
Cite
Save
Citations (2)
Nimotuzumab as a radiosensitizing agent in the treatment of high grade glioma: challenges and opportunities
2013
OncoTargets and Therapy
Arlhee Díaz-Miqueli
Giselle Saurez-Martínez
Show All
Source
Cite
Save
Citations (20)
Current Algorithm for Treatment of Advanced NSCLC Patients: How to Include Active Immunotherapy?
2013
Journal of Cancer Therapy
G. Gonzalez
Arlhee Díaz-Miqueli
Tania Crombet
Luis E. Raez
Agustin Lage
Show All
Source
Cite
Save
Citations (1)
A Potencial Theranostic Agent for EGF-R Expression Tumors: 177Lu- DOTA-Nimotuzumab
2012
Current Radiopharmaceuticals
Victoria Calzada
Xiuli Zhang
Marcelo Fernández
Arlhee Díaz-Miqueli
Normando Iznaga Escobar
Susan L. Deutscher
Henia Balter
Thomas P. Quinn
Pablo Cabral
Show All
Source
Cite
Save
Citations (5)
Biological Activity In Vitro of Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies with Different Affinities
2007
Hybridoma
Arlhee Díaz-Miqueli
Rancés Blanco
Beatriz Garcia
Teresita Badia
Ana E. Batista
Ruby Alonso
Enrique Montero
Show All
Source
Cite
Save
Citations (43)
1